343 related articles for article (PubMed ID: 23433244)
21. Environmental Dependence of Competitive Fitness in Rifampin-Resistant
Leehan JD; Nicholson WL
Appl Environ Microbiol; 2022 Mar; 88(5):e0242221. PubMed ID: 35258334
[TBL] [Abstract][Full Text] [Related]
22. Effects of Beneficial Mutations in pykF Gene Vary over Time and across Replicate Populations in a Long-Term Experiment with Bacteria.
Peng F; Widmann S; Wünsche A; Duan K; Donovan KA; Dobson RCJ; Lenski RE; Cooper TF
Mol Biol Evol; 2018 Jan; 35(1):202-210. PubMed ID: 29069429
[TBL] [Abstract][Full Text] [Related]
23. Adaptive Mutations in RNA Polymerase and the Transcriptional Terminator Rho Have Similar Effects on Escherichia coli Gene Expression.
González-González A; Hug SM; Rodríguez-Verdugo A; Patel JS; Gaut BS
Mol Biol Evol; 2017 Nov; 34(11):2839-2855. PubMed ID: 28961910
[TBL] [Abstract][Full Text] [Related]
24. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
Wang C; Fang R; Zhou B; Tian X; Zhang X; Zheng X; Zhang S; Dong G; Cao J; Zhou T
BMC Microbiol; 2019 Sep; 19(1):220. PubMed ID: 31533633
[TBL] [Abstract][Full Text] [Related]
25. Idiosyncratic variation in the fitness costs of tetracycline-resistance mutations in Escherichia coli.
Card KJ; Jordan JA; Lenski RE
Evolution; 2021 May; 75(5):1230-1238. PubMed ID: 33634468
[TBL] [Abstract][Full Text] [Related]
26. Insights into RNA polymerase catalysis and adaptive evolution gained from mutational analysis of a locus conferring rifampicin resistance.
Yurieva O; Nikiforov V; Nikiforov V; O'Donnell M; Mustaev A
Nucleic Acids Res; 2017 Nov; 45(19):11327-11340. PubMed ID: 29036608
[TBL] [Abstract][Full Text] [Related]
27. Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa.
MacLean RC; Perron GG; Gardner A
Genetics; 2010 Dec; 186(4):1345-54. PubMed ID: 20876562
[TBL] [Abstract][Full Text] [Related]
28. Changes in Intrinsic Antibiotic Susceptibility during a Long-Term Evolution Experiment with Escherichia coli.
Lamrabet O; Martin M; Lenski RE; Schneider D
mBio; 2019 Mar; 10(2):. PubMed ID: 30837336
[TBL] [Abstract][Full Text] [Related]
29. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.
Qi Q; Preston GM; MacLean RC
mBio; 2014 Dec; 5(6):e01562. PubMed ID: 25491352
[TBL] [Abstract][Full Text] [Related]
30. Potential for adaptation overrides cost of resistance.
Moura de Sousa J; Sousa A; Bourgard C; Gordo I
Future Microbiol; 2015; 10(9):1415-31. PubMed ID: 26343510
[TBL] [Abstract][Full Text] [Related]
31. Compensatory effects of
Ma P; Luo T; Ge L; Chen Z; Wang X; Zhao R; Liao W; Bao L
Emerg Microbes Infect; 2021 Dec; 10(1):743-752. PubMed ID: 33775224
[No Abstract] [Full Text] [Related]
32. Predictable properties of fitness landscapes induced by adaptational tradeoffs.
Das SG; Direito SO; Waclaw B; Allen RJ; Krug J
Elife; 2020 May; 9():. PubMed ID: 32423531
[TBL] [Abstract][Full Text] [Related]
33. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates.
Brandis G; Hughes D
J Antimicrob Chemother; 2013 Nov; 68(11):2493-7. PubMed ID: 23759506
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Survival of Rifampin- and Streptomycin-Resistant Escherichia coli Inside Macrophages.
Durão P; Gülereşi D; Proença J; Gordo I
Antimicrob Agents Chemother; 2016 Jul; 60(7):4324-32. PubMed ID: 27161646
[TBL] [Abstract][Full Text] [Related]
35. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
Kothary V; Scherl EJ; Bosworth B; Jiang ZD; Dupont HL; Harel J; Simpson KW; Dogan B
Antimicrob Agents Chemother; 2013 Feb; 57(2):811-7. PubMed ID: 23183443
[TBL] [Abstract][Full Text] [Related]
36. Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.
de Vos M; Müller B; Borrell S; Black PA; van Helden PD; Warren RM; Gagneux S; Victor TC
Antimicrob Agents Chemother; 2013 Feb; 57(2):827-32. PubMed ID: 23208709
[TBL] [Abstract][Full Text] [Related]
37. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.
Jin DJ; Gross CA
J Mol Biol; 1988 Jul; 202(1):45-58. PubMed ID: 3050121
[TBL] [Abstract][Full Text] [Related]
38. Evolutionary rescue from extinction is contingent on a lower rate of environmental change.
Lindsey HA; Gallie J; Taylor S; Kerr B
Nature; 2013 Feb; 494(7438):463-7. PubMed ID: 23395960
[TBL] [Abstract][Full Text] [Related]
39. Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects.
Pietsch F; Bergman JM; Brandis G; Marcusson LL; Zorzet A; Huseby DL; Hughes D
J Antimicrob Chemother; 2017 Jan; 72(1):75-84. PubMed ID: 27621175
[TBL] [Abstract][Full Text] [Related]
40. Rifampicin- and Rifabutin-Resistant Listeria monocytogenes Strains Isolated from Food Products Carry Mutations in rpoB Gene.
Korsak D; Krawczyk-Balska A
Foodborne Pathog Dis; 2016 Jul; 13(7):363-8. PubMed ID: 27105395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
